Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy. - Wikidata - wikimedia - TriplyDB

Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy.

Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy.

http://www.wikidata.org/entity/Q35130521

about

Sirolimus in pediatric renal transplantation.Sirolimus pharmacokinetics in early postmyeloablative pediatric blood and marrow transplantation.Population pharmacokinetics of sirolimus in pediatric patients with neurofibromatosis type 1.mTOR inhibitors in pediatric kidney transplantation.Therapeutic drug monitoring in pediatric renal transplantation.Sirolimus-Induced Hepatitis in Two Cases with Hyperinsulinemic Hypoglycemia.Sirolimus and tacrolimus coefficient of variation is associated with rejection, donor-specific antibodies, and nonadherence.

P2860

Q33397668-143A6DBC-702A-4923-9233-7924BCFB6E81 Q34510280-0E08C0DC-668A-4158-AA3E-7D67AF850E16 Q36865546-0FB3E26E-D3BD-4F7F-81BE-88039F936614 Q38112331-45541D0F-3F5B-4C46-9731-CA3F9636C4A2 Q38206952-030269D8-EFBE-4F1C-A212-6990B0F31E50 Q50021780-739ED05F-5B18-4EF2-86E8-6C7580D47E27 Q53085840-060DE596-85DA-4D82-9523-4F5B5873235C

P2860

Sirolimus pharmacokinetics in pediatric renal transplant recipients receiving calcineurin inhibitor co-therapy.

http://www.wikidata.org/entity/Q35130521

description

2006 nî lūn-bûn

@nan

2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Sirolimus pharmacokinetics in ...... cineurin inhibitor co-therapy.

@ast

Sirolimus pharmacokinetics in ...... cineurin inhibitor co-therapy.

@en

type

label

Sirolimus pharmacokinetics in ...... cineurin inhibitor co-therapy.

@ast

Sirolimus pharmacokinetics in ...... cineurin inhibitor co-therapy.

@en

prefLabel

Sirolimus pharmacokinetics in ...... cineurin inhibitor co-therapy.

@ast

Sirolimus pharmacokinetics in ...... cineurin inhibitor co-therapy.

@en

P1433

Q35130521-EF09A85B-DD40-417B-9E5C-9D3361565289

P1476

Q35130521-E5427352-BF66-4F15-9291-84BAD06BD668

P2093

Q35130521-36F43880-9D94-4301-98C5-830310AF3438

Q35130521-376B26FC-BDA7-483D-85CC-9EDC598FB878

Q35130521-58A52E6C-248D-4D8D-81EC-651A8D634AF0

Q35130521-6D26A253-91D7-428E-B98D-FF9FFA18696A

Q35130521-ABF00535-D411-4F76-A492-18C9FD941557

Q35130521-BA50D43B-0AF6-4EB4-A02B-3B47CC9B654A

Q35130521-CE3400CF-3EDB-4EE7-A6C0-E4C66DF3AE4C

Q35130521-DB7C5EA8-E0C3-4588-A06A-604DD572169E

Q35130521-E224E4EE-589D-4902-92CD-34BEBD7CF9E0

P2860

Q35130521-0BD9F2AF-1B9E-463E-982B-FEDC9FC02C13

Q35130521-27C976FD-152B-48CA-8252-4D79039880DE

Q35130521-2AFAFFC2-4EBB-4DEC-B1F2-DA5B5F8B9DA6

Q35130521-2B245C1E-C603-44F1-BD21-933B8BFBBCEF

Q35130521-30543702-09D3-4479-9F52-A5E3F1B82F69

Q35130521-3168D4B2-D5EE-4671-AF93-79222D14B60A

Q35130521-38A139EE-2568-4BD2-8F1D-AE432B22FE73

Q35130521-3AFCE5A8-C973-4D04-B1A0-20AEDF97CE3B

Q35130521-4262B9D8-60FD-4863-84B3-5CB8F3FED744

Q35130521-56829048-FAD0-4F45-B8F5-536EF0B4029E

P304

Q35130521-9452B8F7-9DC8-42D9-A720-735A775B93EF

P31

Q35130521-73DBE2CD-6302-499F-BDBC-60DCE85B664E

P356

Q35130521-05AFA212-D8AD-4426-BCEE-CAFFCAC4601F

P433

Q35130521-E3A82578-A3F6-459C-844A-4BAD50CF78BC

P478

Q35130521-8C80577B-2C3A-45A3-8EEC-D7FDD0E4FDD0

P50

Q35130521-50DDF96A-4174-463D-8A6A-716F8E6E9CD4

P577

Q35130521-4511DA76-01A2-487E-9694-57D794B76DC6

P5875

Q35130521-05082AF6-2C51-4C91-85FF-E915BF746610

P698

Q35130521-677F6297-34C5-4BBA-A71F-6DFB0A46DFF7

P932

Q35130521-8C759052-38E7-403F-9446-6E322DB87F18

P356

J.1399-3046.2006.00541.X

P1433

Pediatric Transplantation

P1476

Sirolimus pharmacokinetics in ...... cineurin inhibitor co-therapy.

@en

P2093

Asher D Schachter

http://www.w3.org/2001/XMLSchema#string

David S Lirenman

http://www.w3.org/2001/XMLSchema#string

John T Herrin

http://www.w3.org/2001/XMLSchema#string

Mark R Benfield

http://www.w3.org/2001/XMLSchema#string

Paul C Grimm

http://www.w3.org/2001/XMLSchema#string

Ricardo Munoz-Arizpe

http://www.w3.org/2001/XMLSchema#string

Robert S Fennell

http://www.w3.org/2001/XMLSchema#string

Ruth A McDonald

http://www.w3.org/2001/XMLSchema#string

William E Harmon

http://www.w3.org/2001/XMLSchema#string

P2860

Atomic structures of the human immunophilin FKBP-12 complexes with FK506 and rapamycin

Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases

Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.

Kinetics and dynamics of single oral doses of sirolimus in sixteen renal transplant recipients.

Impact of developmental pharmacology on pediatric study design: overcoming the challenges.

Short sirolimus half-life in pediatric renal transplant recipients on a calcineurin inhibitor-free protocol.

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.

Immunosuppressive drug monitoring of sirolimus and cyclosporine in pediatric patients.

Exposure-response relationships and drug interactions of sirolimus

P304

914-919

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-3046.2006.00541.X

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6700186

http://www.w3.org/2001/XMLSchema#string

P698

17096757

http://www.w3.org/2001/XMLSchema#string

P932

1636453

http://www.w3.org/2001/XMLSchema#string